article

The circuit of life: saving on manufacturing, waste and delivery-related supply chain inefficiencies

Many pharmaceutical companies have complicated supply chains that are inefficient and ill-equipped to deal with current demands. This article explores how digitalising the healthcare supply chain can address the pharmaceutical sector’s increasing financial-, capacity- and waste-related strains associated with our ageing population and the soaring costs of new treatments.

Pharmaceutical supply chain

DIGITAL TECHNOLOGIES have long been acknowledged as key enablers in overcoming the healthcare sector’s intractable supply chain challenges. One of the drivers of capacity-related issues includes our population’s ever-increasing life expectancy, which demands a greater number of people receive treatment for more long-term and often, multi-morbid conditions. Wastage throughout the supply chain only exacerbates this problem, through poor patient compliance, over-manufacturing, transport losses and environmental spoil. By embracing digitalisation, from plant to patient, it will be possible to realise dramatic gains in the efficiency and responsiveness of the pharmaceutical supply chain.











To read this article in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

Send this to a friend